These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 15554766)

  • 1. Combining stimulants with monoamine oxidase inhibitors: a review of uses and one possible additional indication.
    Feinberg SS
    J Clin Psychiatry; 2004 Nov; 65(11):1520-4. PubMed ID: 15554766
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination therapy with monoamine oxidase inhibitors and other antidepressants or stimulants: strategies for the management of treatment-resistant depression.
    Thomas SJ; Shin M; McInnis MG; Bostwick JR
    Pharmacotherapy; 2015 Apr; 35(4):433-49. PubMed ID: 25884531
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CNS stimulant potentiation of monoamine oxidase inhibitors in treatment-refractory depression.
    Fawcett J; Kravitz HM; Zajecka JM; Schaff MR
    J Clin Psychopharmacol; 1991 Apr; 11(2):127-32. PubMed ID: 2056139
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined MAOI, TCA, and direct stimulant therapy of treatment-resistant depression.
    Feighner JP; Herbstein J; Damlouji N
    J Clin Psychiatry; 1985 Jun; 46(6):206-9. PubMed ID: 3997787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current prescription patterns and safety profile of irreversible monoamine oxidase inhibitors: a population-based cohort study of older adults.
    Shulman KI; Fischer HD; Herrmann N; Huo CY; Anderson GM; Rochon PA
    J Clin Psychiatry; 2009 Dec; 70(12):1681-6. PubMed ID: 19852903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoamine oxidase inhibitors in resistant major depression. A double-blind comparison of brofaromine and tranylcypromine in patients resistant to tricyclic antidepressants.
    Nolen WA; Haffmans PM; Bouvy PF; Duivenvoorden HJ
    J Affect Disord; 1993 Jul; 28(3):189-97. PubMed ID: 8408980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of hyperactive children with monoamine oxidase inhibitors. I. Clinical efficacy.
    Zametkin A; Rapoport JL; Murphy DL; Linnoila M; Ismond D
    Arch Gen Psychiatry; 1985 Oct; 42(10):962-6. PubMed ID: 3899047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spontaneous hypertensive reactions with monoamine oxidase inhibitors.
    Lavin MR; Mendelowitz A; Kronig MH
    Biol Psychiatry; 1993 Aug; 34(3):146-51. PubMed ID: 8399806
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe daytime somnolence in patients treated with an MAOI.
    Teicher MH; Cohen BM; Baldessarini RJ; Cole JO
    Am J Psychiatry; 1988 Dec; 145(12):1552-6. PubMed ID: 3273886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The selegiline transdermal system in major depressive disorder: a systematic review of safety and tolerability.
    Robinson DS; Amsterdam JD
    J Affect Disord; 2008 Jan; 105(1-3):15-23. PubMed ID: 17568687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addition of monoamine oxidase inhibitors to carbamazepine: preliminary evidence of safety and antidepressant efficacy in treatment-resistant depression.
    Ketter TA; Post RM; Parekh PI; Worthington K
    J Clin Psychiatry; 1995 Oct; 56(10):471-5. PubMed ID: 7559374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Supervised off-label prescribing of methylphenidate in adult ADHD].
    Carton L; Dondaine T; Deheul S; Marquié C; Brigadeau F; Amad A; Devos D; Danel T; Bordet R; Cottencin O; Gautier S; Ménard O
    Encephale; 2019 Feb; 45(1):74-81. PubMed ID: 30122296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combining tricyclic and monoamine oxidase inhibitor antidepressants.
    Spiker DG; Pugh DD
    Arch Gen Psychiatry; 1976 Jul; 33(7):828-30. PubMed ID: 942286
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combining a classic monoamine oxidase inhibitor with a tricyclic antidepressant in therapy-resistant depression: a case report and literature review].
    Schipper P; Vanmolkot L; Peeters FP
    Tijdschr Psychiatr; 2016; 58(12):886-890. PubMed ID: 27976787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The transdermal delivery system of monoamine oxidase inhibitors.
    VanDenBerg CM
    J Clin Psychiatry; 2012; 73 Suppl 1():25-30. PubMed ID: 22951239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined treatment with moclobemide and methylphenidate for comorbid major depression and adult attention-deficit/hyperactivity disorder.
    Myronuk LD; Weiss M; Cotter L
    J Clin Psychopharmacol; 1996 Dec; 16(6):468-9. PubMed ID: 8959481
    [No Abstract]   [Full Text] [Related]  

  • 17. Bupropion treatment of attention-deficit hyperactivity disorder in adults.
    Wender PH; Reimherr FW
    Am J Psychiatry; 1990 Aug; 147(8):1018-20. PubMed ID: 2115746
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The use of monoamine oxidase inhibitors in primary care.
    Culpepper L
    J Clin Psychiatry; 2012; 73 Suppl 1():37-41. PubMed ID: 22951241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Elderly patients, classical monoamine oxidase inhibitors and intercurrent somatic diseases].
    Oostervink F; Bouvy PF; Touw DJ
    Ned Tijdschr Geneeskd; 2003 Oct; 147(40):1937-40. PubMed ID: 14574773
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monoamine oxidase inhibitor hypertensive crisis headache and orthostatic hypotension.
    Golwyn DH; Sevlie CP
    J Clin Psychopharmacol; 1993 Feb; 13(1):77-8. PubMed ID: 8486823
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.